☆ 4.7 Article

Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Microbiology

Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection

Danielle A. Nicklas et al.

Summary: The incidence of nontuberculous mycobacterial diseases in the United States is rising and has surpassed that of tuberculosis. Mycobacteroides abscessus is an important pathogen capable of causing chronic infections and is difficult to treat. The study found that omadacycline, a new tetracycline derivative, showed activity against M. abscessus and exhibited synergism with several commonly used antibiotics.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

添加到收藏夹

Article Infectious Diseases

Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses

Moti Chapagain et al.

Summary: The standard treatment for pulmonary Mycobacterium avium complex (MAC) disease has limited efficacy, prompting the exploration of new treatment options. This study suggests that omadacycline may be a potential treatment option for pulmonary MAC, possibly as the main therapy in a new MAC regimen, but further research is needed to confirm its effectiveness.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

添加到收藏夹

Article Infectious Diseases

Omadacycline in first-line combination therapy for pulmonary Mycobacterium abscessus infection: a case series

Marylene Duah et al.

Summary: Mycobacterium abscessus complex (MABSC) is a common cause of nontuberculous mycobacterial pulmonary disease, but there are currently no approved treatments. This study reports on three cases where omadacycline was used as part of a first-line treatment for patients with MABSC pulmonary infections, showing promising clinical improvements and supporting further investigation of omadacycline as a potential treatment option.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Microbiology

In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria

Barbara A. Brown-Elliott et al.

Summary: This study evaluated the in vitro potency of the new tetracycline derivative omadacycline against NTM, showing high activity against most RGM species. MIC testing against RGM revealed over 90% resistance to tetracycline in the isolates tested.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Immunology

Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections

Taylor Morrisette et al.

Summary: In this study, 12 patients with Mycobacterium abscessus infection were treated with omadacycline as part of a multidrug regimen. The median duration of OMC treatment was relatively long, and overall clinical success was observed in 75% of patients, with three patients experiencing possible adverse effects.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus

Bui Thi Bich Hanh et al.

Summary: This study identified a strong, positive synergy between clarithromycin and omadacycline against M. abscessus, showing effective inhibition of pathogen growth and dissemination, as well as significantly extending the lifespan of infected animals.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Letter Respiratory System

What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey

Michal Shteinberg et al.

ERJ OPEN RESEARCH (2021)

添加到收藏夹

Article Infectious Diseases

Repurposing drugs for treatment of Mycobacterium abscessus: a view to a kill

Tawanda Gumbo et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

添加到收藏夹

Article Immunology

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary

Charles L. Daley et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Immunology

Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series

Jeffrey C. Pearson et al.

OPEN FORUM INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Microbiology

In Vitro Activities of Omadacycline against Rapidly Growing Mycobacteria

Carolyn Shoen et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

添加到收藏夹

Article Infectious Diseases

Once-a-week tigecycline for the treatment of drug-resistant TB

Devyani Deshpande et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

添加到收藏夹

Article Microbiology

In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus

Amit Kaushik et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

添加到收藏夹

Article Infectious Diseases

Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus

Hannelore I. Bax et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

添加到收藏夹

Article Microbiology

Phylogenomics and Comparative Genomic Studies Robustly Support Division of the Genus Mycobacterium into an Emended Genus Mycobacterium and Four Novel Genera

Radhey S. Gupta et al.

FRONTIERS IN MICROBIOLOGY (2018)

添加到收藏夹

Article Immunology

Pharmacokinetic/Pharmacodynamic Background and Methods and Scientific Evidence Base for Dosing of Second-line Tuberculosis Drugs

Tawanda Gumbo et al.

CLINICAL INFECTIOUS DISEASES (2018)

添加到收藏夹

Article Infectious Diseases

Meta-analyses and the evidence base for microbial outcomes in the treatment of pulmonary Mycobacterium avium-intracellulare complex disease

Jotam G. Pasipanodya et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

添加到收藏夹

Article Microbiology

Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence

Jotam G. Pasipanodya et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

添加到收藏夹

Article Microbiology

Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects

Mark H. Gotfried et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

添加到收藏夹

Article Microbiology

Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model

Beatriz E. Ferro et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

添加到收藏夹

Article Microbiology

Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease

Beatriz E. Ferro et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

添加到收藏夹

Article Microbiology

Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease

Beatriz E. Ferro et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

添加到收藏夹

Article Microbiology

Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection

Beatriz E. Ferro et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

添加到收藏夹

Article Immunology

Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia

Tawanda Gumbo et al.

JOURNAL OF INFECTIOUS DISEASES (2015)

添加到收藏夹

Article Immunology

A Meta-Analysis of Self-Administered vs Directly Observed Therapy Effect on Microbiologic Failure, Relapse, and Acquired Drug Resistance in Tuberculosis Patients

Jotam G. Pasipanodya et al.

CLINICAL INFECTIOUS DISEASES (2013)

添加到收藏夹

Article Immunology

Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy

Jotam G. Pasipanodya et al.

CLINICAL INFECTIOUS DISEASES (2012)

添加到收藏夹

Editorial Material Immunology

The Talking Mycobacterium abscessus Blues

David E. Griffith

CLINICAL INFECTIOUS DISEASES (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.